nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP1A2—schizophrenia	0.403	0.564	CbGaD
Irbesartan—CYP2D6—schizophrenia	0.311	0.436	CbGaD
Irbesartan—AGTR1—blood plasma—schizophrenia	0.00383	0.0521	CbGeAlD
Irbesartan—CYP1A2—urine—schizophrenia	0.00372	0.0506	CbGeAlD
Irbesartan—CYP2C9—urine—schizophrenia	0.00354	0.048	CbGeAlD
Irbesartan—UGT1A3—endocrine gland—schizophrenia	0.00286	0.0388	CbGeAlD
Irbesartan—JUN—forebrain—schizophrenia	0.00279	0.0379	CbGeAlD
Irbesartan—CYP3A4—urine—schizophrenia	0.0027	0.0366	CbGeAlD
Irbesartan—CYP2D6—urine—schizophrenia	0.00265	0.036	CbGeAlD
Irbesartan—JUN—telencephalon—schizophrenia	0.00256	0.0348	CbGeAlD
Irbesartan—JUN—gonad—schizophrenia	0.00214	0.0291	CbGeAlD
Irbesartan—AGTR1—forebrain—schizophrenia	0.0021	0.0285	CbGeAlD
Irbesartan—CYP2C8—blood plasma—schizophrenia	0.00208	0.0282	CbGeAlD
Irbesartan—EDNRA—midbrain—schizophrenia	0.00202	0.0274	CbGeAlD
Irbesartan—CYP1A2—blood plasma—schizophrenia	0.00194	0.0264	CbGeAlD
Irbesartan—JUN—blood—schizophrenia	0.00186	0.0253	CbGeAlD
Irbesartan—CYP2C9—blood plasma—schizophrenia	0.00184	0.0251	CbGeAlD
Irbesartan—JUN—midbrain—schizophrenia	0.00184	0.025	CbGeAlD
Irbesartan—PTGS1—blood plasma—schizophrenia	0.00168	0.0229	CbGeAlD
Irbesartan—JUN—endocrine gland—schizophrenia	0.00162	0.022	CbGeAlD
Irbesartan—JUN—nervous system—schizophrenia	0.00151	0.0206	CbGeAlD
Irbesartan—JUN—central nervous system—schizophrenia	0.00146	0.0198	CbGeAlD
Irbesartan—JUN—cerebellum—schizophrenia	0.00142	0.0193	CbGeAlD
Irbesartan—CYP3A4—blood plasma—schizophrenia	0.00141	0.0191	CbGeAlD
Irbesartan—AGTR1—blood—schizophrenia	0.0014	0.0191	CbGeAlD
Irbesartan—CYP2D6—blood plasma—schizophrenia	0.00138	0.0188	CbGeAlD
Irbesartan—EDNRA—brain—schizophrenia	0.00127	0.0172	CbGeAlD
Irbesartan—AGTR1—endocrine gland—schizophrenia	0.00122	0.0165	CbGeAlD
Irbesartan—JUN—brain—schizophrenia	0.00116	0.0157	CbGeAlD
Irbesartan—AGTR1—nervous system—schizophrenia	0.00114	0.0155	CbGeAlD
Irbesartan—AGTR1—central nervous system—schizophrenia	0.0011	0.0149	CbGeAlD
Irbesartan—PTGS1—forebrain—schizophrenia	0.000923	0.0125	CbGeAlD
Irbesartan—AGTR1—brain—schizophrenia	0.000871	0.0118	CbGeAlD
Irbesartan—PTGS1—telencephalon—schizophrenia	0.000848	0.0115	CbGeAlD
Irbesartan—CYP2C8—blood—schizophrenia	0.000761	0.0103	CbGeAlD
Irbesartan—CYP2D6—forebrain—schizophrenia	0.000758	0.0103	CbGeAlD
Irbesartan—CYP1A2—blood—schizophrenia	0.000712	0.00968	CbGeAlD
Irbesartan—Losartan—ACE—schizophrenia	0.000702	0.369	CrCbGaD
Irbesartan—CYP2D6—telencephalon—schizophrenia	0.000697	0.00948	CbGeAlD
Irbesartan—CYP2C9—blood—schizophrenia	0.000676	0.00919	CbGeAlD
Irbesartan—CYP2C8—endocrine gland—schizophrenia	0.00066	0.00897	CbGeAlD
Irbesartan—CYP1A2—endocrine gland—schizophrenia	0.000618	0.00839	CbGeAlD
Irbesartan—PTGS1—blood—schizophrenia	0.000617	0.00839	CbGeAlD
Irbesartan—CYP2C9—endocrine gland—schizophrenia	0.000586	0.00797	CbGeAlD
Irbesartan—PTGS1—endocrine gland—schizophrenia	0.000535	0.00727	CbGeAlD
Irbesartan—CYP3A4—blood—schizophrenia	0.000515	0.007	CbGeAlD
Irbesartan—CYP2D6—blood—schizophrenia	0.000507	0.00689	CbGeAlD
Irbesartan—PTGS1—nervous system—schizophrenia	0.000501	0.00681	CbGeAlD
Irbesartan—Losartan—CYP1A2—schizophrenia	0.000498	0.262	CrCbGaD
Irbesartan—PTGS1—central nervous system—schizophrenia	0.000482	0.00655	CbGeAlD
Irbesartan—CYP2C8—brain—schizophrenia	0.000472	0.00642	CbGeAlD
Irbesartan—CYP3A4—endocrine gland—schizophrenia	0.000447	0.00607	CbGeAlD
Irbesartan—CYP2D6—endocrine gland—schizophrenia	0.00044	0.00598	CbGeAlD
Irbesartan—Candesartan—ABCB1—schizophrenia	0.000426	0.224	CrCbGaD
Irbesartan—CYP3A4—nervous system—schizophrenia	0.000418	0.00569	CbGeAlD
Irbesartan—CYP2D6—nervous system—schizophrenia	0.000412	0.0056	CbGeAlD
Irbesartan—CYP3A4—central nervous system—schizophrenia	0.000403	0.00547	CbGeAlD
Irbesartan—CYP2D6—central nervous system—schizophrenia	0.000396	0.00539	CbGeAlD
Irbesartan—CYP2D6—cerebellum—schizophrenia	0.000387	0.00527	CbGeAlD
Irbesartan—PTGS1—brain—schizophrenia	0.000383	0.0052	CbGeAlD
Irbesartan—CYP2D6—brain—schizophrenia	0.000315	0.00428	CbGeAlD
Irbesartan—Losartan—ABCB1—schizophrenia	0.000274	0.144	CrCbGaD
Irbesartan—JUN—Signaling Pathways—HTR1A—schizophrenia	2.56e-05	0.000121	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—S100B—schizophrenia	2.55e-05	0.000121	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PNP—schizophrenia	2.55e-05	0.000121	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PLA2G4A—schizophrenia	2.54e-05	0.00012	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—DPYD—schizophrenia	2.54e-05	0.00012	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GSTM1—schizophrenia	2.54e-05	0.00012	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NPS—schizophrenia	2.52e-05	0.00012	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NDST3—schizophrenia	2.51e-05	0.000119	CbGpPWpGaD
Irbesartan—JUN—Immune System—YWHAZ—schizophrenia	2.5e-05	0.000118	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2C—schizophrenia	2.48e-05	0.000117	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD1—schizophrenia	2.48e-05	0.000117	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP26B1—schizophrenia	2.47e-05	0.000117	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB4—schizophrenia	2.44e-05	0.000116	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERBB3—schizophrenia	2.44e-05	0.000116	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOE—schizophrenia	2.41e-05	0.000114	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NTRK2—schizophrenia	2.41e-05	0.000114	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD3—schizophrenia	2.4e-05	0.000114	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NDUFV2—schizophrenia	2.39e-05	0.000113	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOA1—schizophrenia	2.38e-05	0.000113	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ACSL6—schizophrenia	2.38e-05	0.000113	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC27A5—schizophrenia	2.38e-05	0.000113	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NDUFV2—schizophrenia	2.37e-05	0.000112	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CACNA1C—schizophrenia	2.36e-05	0.000112	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD4—schizophrenia	2.33e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	2.32e-05	0.00011	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3C2A—schizophrenia	2.3e-05	0.000109	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ESR1—schizophrenia	2.3e-05	0.000109	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PLA2G4A—schizophrenia	2.3e-05	0.000109	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DAO—schizophrenia	2.27e-05	0.000107	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NRG1—schizophrenia	2.25e-05	0.000107	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MTHFR—schizophrenia	2.25e-05	0.000106	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIP4K2A—schizophrenia	2.24e-05	0.000106	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MEF2C—schizophrenia	2.23e-05	0.000106	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIP4K2A—schizophrenia	2.23e-05	0.000105	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CNR1—schizophrenia	2.22e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MPC2—schizophrenia	2.22e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	2.21e-05	0.000104	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GCLM—schizophrenia	2.2e-05	0.000104	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TPH1—schizophrenia	2.2e-05	0.000104	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PNP—schizophrenia	2.18e-05	0.000103	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR7—schizophrenia	2.17e-05	0.000103	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD2—schizophrenia	2.17e-05	0.000103	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—YWHAZ—schizophrenia	2.16e-05	0.000102	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EP300—schizophrenia	2.14e-05	0.000101	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB3—schizophrenia	2.11e-05	0.0001	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—schizophrenia	2.09e-05	9.91e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—GSK3B—schizophrenia	2.09e-05	9.88e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	2.08e-05	9.84e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PRKD1—schizophrenia	2.07e-05	9.81e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOA1—schizophrenia	2.07e-05	9.8e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SNAP25—schizophrenia	2.07e-05	9.79e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP2D6—schizophrenia	2.07e-05	9.79e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLCH2—schizophrenia	2.06e-05	9.75e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRL—schizophrenia	2.05e-05	9.7e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2A—schizophrenia	2.03e-05	9.63e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP26B1—schizophrenia	2.03e-05	9.61e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NDUFV2—schizophrenia	2.02e-05	9.58e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP26B1—schizophrenia	2.01e-05	9.53e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NDST3—schizophrenia	1.94e-05	9.17e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—S100B—schizophrenia	1.91e-05	9.04e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIP4K2A—schizophrenia	1.9e-05	9e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—GSK3B—schizophrenia	1.89e-05	8.95e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—schizophrenia	1.89e-05	8.95e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—FOS—schizophrenia	1.88e-05	8.9e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP1A2—schizophrenia	1.87e-05	8.85e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOA1—schizophrenia	1.87e-05	8.85e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TH—schizophrenia	1.84e-05	8.72e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC27A5—schizophrenia	1.84e-05	8.69e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ACSL6—schizophrenia	1.84e-05	8.69e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB4—schizophrenia	1.83e-05	8.64e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GCLM—schizophrenia	1.81e-05	8.57e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TPH1—schizophrenia	1.81e-05	8.57e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ESR1—schizophrenia	1.8e-05	8.54e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GCLM—schizophrenia	1.79e-05	8.49e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TPH1—schizophrenia	1.79e-05	8.49e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DAO—schizophrenia	1.75e-05	8.29e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GAPDH—schizophrenia	1.73e-05	8.19e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP26B1—schizophrenia	1.72e-05	8.14e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PLA2G4A—schizophrenia	1.72e-05	8.13e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CLOCK—schizophrenia	1.71e-05	8.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.71e-05	8.09e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PRKD1—schizophrenia	1.7e-05	8.05e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.69e-05	8.01e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.69e-05	8e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PRKD1—schizophrenia	1.69e-05	7.98e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NRG1—schizophrenia	1.68e-05	7.98e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PNP—schizophrenia	1.68e-05	7.95e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TPH2—schizophrenia	1.67e-05	7.91e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CACNB2—schizophrenia	1.67e-05	7.91e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MEF2C—schizophrenia	1.67e-05	7.9e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DPYD—schizophrenia	1.64e-05	7.78e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—GSK3B—schizophrenia	1.64e-05	7.75e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—YWHAZ—schizophrenia	1.61e-05	7.64e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB3—schizophrenia	1.58e-05	7.47e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—COMT—schizophrenia	1.57e-05	7.42e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.56e-05	7.39e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTP1—schizophrenia	1.56e-05	7.38e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MAOA—schizophrenia	1.56e-05	7.36e-05	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AKT1—schizophrenia	1.55e-05	7.32e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TPH1—schizophrenia	1.53e-05	7.26e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GCLM—schizophrenia	1.53e-05	7.26e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CACNA1C—schizophrenia	1.53e-05	7.23e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2A—schizophrenia	1.52e-05	7.19e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.51e-05	7.14e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3C2A—schizophrenia	1.49e-05	7.05e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCB1—schizophrenia	1.48e-05	6.99e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.47e-05	6.95e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.45e-05	6.84e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PRKD1—schizophrenia	1.44e-05	6.82e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PLA2G4A—schizophrenia	1.43e-05	6.78e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTM1—schizophrenia	1.43e-05	6.78e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GAPDH—schizophrenia	1.42e-05	6.72e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—schizophrenia	1.41e-05	6.69e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GAPDH—schizophrenia	1.41e-05	6.66e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CLOCK—schizophrenia	1.41e-05	6.66e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AKT1—schizophrenia	1.4e-05	6.65e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOA1—schizophrenia	1.4e-05	6.61e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CLOCK—schizophrenia	1.39e-05	6.6e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—schizophrenia	1.39e-05	6.59e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.39e-05	6.59e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.38e-05	6.51e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EP300—schizophrenia	1.37e-05	6.5e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CACNB2—schizophrenia	1.37e-05	6.49e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TPH2—schizophrenia	1.37e-05	6.49e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TPH2—schizophrenia	1.36e-05	6.44e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CACNB2—schizophrenia	1.36e-05	6.44e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DPYD—schizophrenia	1.35e-05	6.39e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ESR1—schizophrenia	1.35e-05	6.38e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DPYD—schizophrenia	1.34e-05	6.33e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2D6—schizophrenia	1.34e-05	6.32e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SNAP25—schizophrenia	1.34e-05	6.32e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.33e-05	6.28e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—AKT1—schizophrenia	1.29e-05	6.11e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—schizophrenia	1.27e-05	6e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CACNA1C—schizophrenia	1.25e-05	5.94e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—EP300—schizophrenia	1.24e-05	5.89e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CACNA1C—schizophrenia	1.24e-05	5.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GSK3B—schizophrenia	1.22e-05	5.79e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3C2A—schizophrenia	1.22e-05	5.79e-05	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AKT1—schizophrenia	1.21e-05	5.74e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3C2A—schizophrenia	1.21e-05	5.74e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP1A2—schizophrenia	1.21e-05	5.72e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GAPDH—schizophrenia	1.2e-05	5.69e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—EP300—schizophrenia	1.19e-05	5.65e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CLOCK—schizophrenia	1.19e-05	5.64e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TH—schizophrenia	1.19e-05	5.63e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.19e-05	5.63e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCLM—schizophrenia	1.18e-05	5.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TPH1—schizophrenia	1.18e-05	5.6e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—schizophrenia	1.18e-05	5.58e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.18e-05	5.57e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOA1—schizophrenia	1.17e-05	5.52e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TPH2—schizophrenia	1.16e-05	5.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNB2—schizophrenia	1.16e-05	5.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DPYD—schizophrenia	1.14e-05	5.41e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PRKD1—schizophrenia	1.11e-05	5.27e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AKT1—schizophrenia	1.1e-05	5.22e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SNAP25—schizophrenia	1.1e-05	5.19e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2D6—schizophrenia	1.09e-05	5.14e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SNAP25—schizophrenia	1.09e-05	5.14e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EP300—schizophrenia	1.08e-05	5.1e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNA1C—schizophrenia	1.06e-05	5.03e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3C2A—schizophrenia	1.04e-05	4.9e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—COMT—schizophrenia	1.01e-05	4.79e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTP1—schizophrenia	1.01e-05	4.77e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOA—schizophrenia	1e-05	4.76e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP1A2—schizophrenia	9.91e-06	4.69e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP1A2—schizophrenia	9.83e-06	4.65e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—schizophrenia	9.82e-06	4.65e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TH—schizophrenia	9.77e-06	4.63e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	9.74e-06	4.61e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TH—schizophrenia	9.68e-06	4.59e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCB1—schizophrenia	9.53e-06	4.51e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2D6—schizophrenia	9.29e-06	4.4e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SNAP25—schizophrenia	9.29e-06	4.4e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GAPDH—schizophrenia	9.28e-06	4.39e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLA2G4A—schizophrenia	9.25e-06	4.38e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTM1—schizophrenia	9.25e-06	4.38e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CLOCK—schizophrenia	9.2e-06	4.36e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNB2—schizophrenia	8.96e-06	4.24e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TPH2—schizophrenia	8.96e-06	4.24e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DPYD—schizophrenia	8.82e-06	4.18e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—COMT—schizophrenia	8.31e-06	3.93e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AKT1—schizophrenia	8.29e-06	3.93e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TH—schizophrenia	8.28e-06	3.92e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTP1—schizophrenia	8.27e-06	3.91e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOA—schizophrenia	8.25e-06	3.91e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—COMT—schizophrenia	8.23e-06	3.9e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNA1C—schizophrenia	8.2e-06	3.88e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTP1—schizophrenia	8.2e-06	3.88e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—schizophrenia	8.18e-06	3.87e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOA—schizophrenia	8.18e-06	3.87e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EP300—schizophrenia	8.05e-06	3.81e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3C2A—schizophrenia	7.99e-06	3.78e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	7.93e-06	3.75e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCB1—schizophrenia	7.83e-06	3.71e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCB1—schizophrenia	7.76e-06	3.67e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—schizophrenia	7.71e-06	3.65e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—schizophrenia	7.61e-06	3.61e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLA2G4A—schizophrenia	7.6e-06	3.6e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTM1—schizophrenia	7.6e-06	3.6e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTM1—schizophrenia	7.53e-06	3.57e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLA2G4A—schizophrenia	7.53e-06	3.57e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOA1—schizophrenia	7.53e-06	3.56e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—AKT1—schizophrenia	7.52e-06	3.56e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AKT1—schizophrenia	7.21e-06	3.41e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2D6—schizophrenia	7.17e-06	3.39e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SNAP25—schizophrenia	7.17e-06	3.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—COMT—schizophrenia	7.04e-06	3.33e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTP1—schizophrenia	7e-06	3.32e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOA—schizophrenia	6.99e-06	3.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.78e-06	3.21e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—EP300—schizophrenia	6.72e-06	3.18e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—schizophrenia	6.71e-06	3.18e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—schizophrenia	6.66e-06	3.15e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCB1—schizophrenia	6.63e-06	3.14e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AKT1—schizophrenia	6.51e-06	3.08e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP1A2—schizophrenia	6.48e-06	3.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLA2G4A—schizophrenia	6.44e-06	3.05e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM1—schizophrenia	6.44e-06	3.05e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TH—schizophrenia	6.39e-06	3.02e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—schizophrenia	6.25e-06	2.96e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—schizophrenia	6.2e-06	2.93e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA1—schizophrenia	6.18e-06	2.93e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA1—schizophrenia	6.13e-06	2.9e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—schizophrenia	5.76e-06	2.73e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—schizophrenia	5.69e-06	2.69e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—COMT—schizophrenia	5.43e-06	2.57e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTP1—schizophrenia	5.41e-06	2.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOA—schizophrenia	5.39e-06	2.55e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—schizophrenia	5.3e-06	2.51e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA1—schizophrenia	5.23e-06	2.48e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCB1—schizophrenia	5.12e-06	2.42e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G4A—schizophrenia	4.97e-06	2.35e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM1—schizophrenia	4.97e-06	2.35e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AKT1—schizophrenia	4.86e-06	2.3e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—schizophrenia	4.39e-06	2.08e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—EP300—schizophrenia	4.34e-06	2.05e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—schizophrenia	4.09e-06	1.94e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AKT1—schizophrenia	4.06e-06	1.92e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA1—schizophrenia	4.04e-06	1.91e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—EP300—schizophrenia	3.56e-06	1.69e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—EP300—schizophrenia	3.53e-06	1.67e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—EP300—schizophrenia	3.02e-06	1.43e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKT1—schizophrenia	2.62e-06	1.24e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—EP300—schizophrenia	2.33e-06	1.1e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKT1—schizophrenia	2.15e-06	1.02e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKT1—schizophrenia	2.13e-06	1.01e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKT1—schizophrenia	1.82e-06	8.63e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKT1—schizophrenia	1.41e-06	6.66e-06	CbGpPWpGaD
